ISIN | CH0271797331 |
---|---|
Valor Number | 27179733 |
Bloomberg Global ID | VAKSFEH SW |
Fund Name | VVA - Aktien Schweiz F (EUR hedged) |
Fund Provider |
UBS Switzerland AG, Zurich
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Other Funds |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 145.62 EUR | 01.11.2024 |
---|---|---|
Previous Price * | 143.27 EUR | 31.10.2024 |
52 Week High * | 150.76 EUR | 02.09.2024 |
52 Week Low * | 122.99 EUR | 10.11.2023 |
NAV * | 145.62 EUR | 01.11.2024 |
Issue Price * | 145.62 EUR | 01.11.2024 |
Redemption Price * | 145.62 EUR | 01.11.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,687,462,692 | |
Unit/Share Assets *** | 7,562,934 | |
Trading Information SIX |
YTD Performance | +12.24% |
29.12.2023 - 01.11.2024
29.12.2023 01.11.2024 |
---|---|---|
YTD Performance (in CHF) | +13.91% |
29.12.2023 - 01.11.2024
29.12.2023 01.11.2024 |
1 month | -0.66% |
01.10.2024 - 01.11.2024
01.10.2024 01.11.2024 |
3 months | +1.48% |
02.08.2024 - 01.11.2024
02.08.2024 01.11.2024 |
6 months | +8.12% |
02.05.2024 - 01.11.2024
02.05.2024 01.11.2024 |
1 year | +18.97% |
01.11.2023 - 01.11.2024
01.11.2023 01.11.2024 |
2 years | +19.66% |
01.11.2022 - 01.11.2024
01.11.2022 01.11.2024 |
3 years | +4.36% |
01.11.2021 - 01.11.2024
01.11.2021 01.11.2024 |
5 years | +30.35% |
01.11.2019 - 01.11.2024
01.11.2019 01.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 6.74% | |
---|---|---|
Roche Holding AG | 4.79% | |
Nestle SA | 4.44% | |
Zurich Insurance Group AG | 3.53% | |
ABB Ltd | 3.05% | |
Compagnie Financiere Richemont SA Class A | 2.16% | |
Holcim Ltd | 2.01% | |
Alcon Inc | 1.81% | |
Swiss Life Holding AG | 1.74% | |
Lonza Group Ltd | 1.47% | |
Last data update | 30.09.2024 |
TER | 0.53% |
---|---|
TER date | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.50% |
Ongoing Charges *** | 0.53% |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |